vs
Kinetik Holdings Inc.（KNTK）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Kinetik Holdings Inc.的1.8倍（$772.1M vs $430.4M），Kinetik Holdings Inc.净利率更高（96.8% vs 12.7%，领先84.1%），Kinetik Holdings Inc.同比增速更快（11.6% vs 5.9%），Revvity自由现金流更多（$161.8M vs $-24.0M），过去两年Kinetik Holdings Inc.的营收复合增速更高（12.3% vs 9.0%）
Kinetik Holdings Inc.是一家聚焦二叠纪盆地的中游能源基础设施供应商，为美国南部核心油气产区的上游作业方提供天然气收集、处理、运输、存储，以及原油、采出水处置等一体化服务。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
KNTK vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.8倍
$430.4M
营收增速更快
KNTK
高出5.7%
5.9%
净利率更高
KNTK
高出84.1%
12.7%
自由现金流更多
RVTY
多$185.8M
$-24.0M
两年增速更快
KNTK
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $430.4M | $772.1M |
| 净利润 | $416.7M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 11.2% | 14.5% |
| 净利率 | 96.8% | 12.7% |
| 营收同比 | 11.6% | 5.9% |
| 净利润同比 | 2468.4% | 3.9% |
| 每股收益（稀释后） | $2.22 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KNTKRVTY
| Q4 25 | $430.4M | $772.1M | ||
| Q3 25 | $464.0M | $698.9M | ||
| Q2 25 | $426.7M | $720.3M | ||
| Q1 25 | $443.3M | $664.8M | ||
| Q4 24 | $385.7M | $729.4M | ||
| Q3 24 | $396.4M | $684.0M | ||
| Q2 24 | $359.5M | $691.7M | ||
| Q1 24 | $341.4M | $649.9M |
净利润KNTKRVTY
| Q4 25 | $416.7M | $98.4M | ||
| Q3 25 | $5.3M | $46.7M | ||
| Q2 25 | $23.6M | $53.9M | ||
| Q1 25 | $19.3M | $42.2M | ||
| Q4 24 | $16.2M | $94.6M | ||
| Q3 24 | $25.8M | $94.4M | ||
| Q2 24 | $37.2M | $55.4M | ||
| Q1 24 | $233.6M | $26.0M |
毛利率KNTKRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率KNTKRVTY
| Q4 25 | 11.2% | 14.5% | ||
| Q3 25 | 4.3% | 11.7% | ||
| Q2 25 | 18.2% | 12.6% | ||
| Q1 25 | 4.3% | 10.9% | ||
| Q4 24 | 6.1% | 16.3% | ||
| Q3 24 | 18.4% | 14.3% | ||
| Q2 24 | 15.7% | 12.4% | ||
| Q1 24 | 7.6% | 6.8% |
净利率KNTKRVTY
| Q4 25 | 96.8% | 12.7% | ||
| Q3 25 | 1.1% | 6.7% | ||
| Q2 25 | 5.5% | 7.5% | ||
| Q1 25 | 4.3% | 6.4% | ||
| Q4 24 | 4.2% | 13.0% | ||
| Q3 24 | 6.5% | 13.8% | ||
| Q2 24 | 10.3% | 8.0% | ||
| Q1 24 | 68.4% | 4.0% |
每股收益（稀释后）KNTKRVTY
| Q4 25 | $2.22 | $0.86 | ||
| Q3 25 | $0.03 | $0.40 | ||
| Q2 25 | $0.33 | $0.46 | ||
| Q1 25 | $0.05 | $0.35 | ||
| Q4 24 | $0.01 | $0.77 | ||
| Q3 24 | $0.35 | $0.77 | ||
| Q2 24 | $0.54 | $0.45 | ||
| Q1 24 | $0.12 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.0M | $919.9M |
| 总债务越低越好 | $3.6B | — |
| 股东权益账面价值 | $-565.4M | $7.3B |
| 总资产 | $7.1B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KNTKRVTY
| Q4 25 | $4.0M | $919.9M | ||
| Q3 25 | $7.7M | $931.4M | ||
| Q2 25 | $10.7M | $991.8M | ||
| Q1 25 | $8.8M | $1.1B | ||
| Q4 24 | $3.6M | $1.2B | ||
| Q3 24 | $20.4M | $1.2B | ||
| Q2 24 | $12.5M | $2.0B | ||
| Q1 24 | $9.8M | $1.7B |
总债务KNTKRVTY
| Q4 25 | $3.6B | — | ||
| Q3 25 | $4.0B | — | ||
| Q2 25 | $3.7B | — | ||
| Q1 25 | $3.6B | — | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | $3.3B | — | ||
| Q2 24 | $3.3B | — | ||
| Q1 24 | $3.5B | — |
股东权益KNTKRVTY
| Q4 25 | $-565.4M | $7.3B | ||
| Q3 25 | $-1.8B | $7.4B | ||
| Q2 25 | $-1.6B | $7.6B | ||
| Q1 25 | $-2.5B | $7.6B | ||
| Q4 24 | $-3.0B | $7.7B | ||
| Q3 24 | $-1.7B | $7.9B | ||
| Q2 24 | $-1.2B | $7.9B | ||
| Q1 24 | $-973.4M | $7.8B |
总资产KNTKRVTY
| Q4 25 | $7.1B | $12.2B | ||
| Q3 25 | $7.2B | $12.1B | ||
| Q2 25 | $7.2B | $12.4B | ||
| Q1 25 | $7.0B | $12.4B | ||
| Q4 24 | $6.8B | $12.4B | ||
| Q3 24 | $6.9B | $12.8B | ||
| Q2 24 | $6.9B | $13.4B | ||
| Q1 24 | $6.4B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $110.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-24.0M | $161.8M |
| 自由现金流率自由现金流/营收 | -5.6% | 21.0% |
| 资本支出强度资本支出/营收 | 31.2% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.26× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $111.6M | $509.4M |
8季度趋势，按日历期对齐
经营现金流KNTKRVTY
| Q4 25 | $110.1M | $182.0M | ||
| Q3 25 | $188.1M | $138.5M | ||
| Q2 25 | $129.1M | $134.3M | ||
| Q1 25 | $176.8M | $128.2M | ||
| Q4 24 | $144.0M | $174.2M | ||
| Q3 24 | $214.1M | $147.9M | ||
| Q2 24 | $125.5M | $158.6M | ||
| Q1 24 | $153.7M | $147.6M |
自由现金流KNTKRVTY
| Q4 25 | $-24.0M | $161.8M | ||
| Q3 25 | $31.6M | $120.0M | ||
| Q2 25 | $1.8M | $115.5M | ||
| Q1 25 | $102.3M | $112.2M | ||
| Q4 24 | $36.3M | $149.8M | ||
| Q3 24 | $155.7M | $125.6M | ||
| Q2 24 | $86.1M | $136.6M | ||
| Q1 24 | $95.7M | $129.7M |
自由现金流率KNTKRVTY
| Q4 25 | -5.6% | 21.0% | ||
| Q3 25 | 6.8% | 17.2% | ||
| Q2 25 | 0.4% | 16.0% | ||
| Q1 25 | 23.1% | 16.9% | ||
| Q4 24 | 9.4% | 20.5% | ||
| Q3 24 | 39.3% | 18.4% | ||
| Q2 24 | 24.0% | 19.7% | ||
| Q1 24 | 28.0% | 20.0% |
资本支出强度KNTKRVTY
| Q4 25 | 31.2% | 2.6% | ||
| Q3 25 | 33.7% | 2.6% | ||
| Q2 25 | 29.8% | 2.6% | ||
| Q1 25 | 16.8% | 2.4% | ||
| Q4 24 | 27.9% | 3.4% | ||
| Q3 24 | 14.7% | 3.3% | ||
| Q2 24 | 11.0% | 3.2% | ||
| Q1 24 | 17.0% | 2.7% |
现金转化率KNTKRVTY
| Q4 25 | 0.26× | 1.85× | ||
| Q3 25 | 35.73× | 2.97× | ||
| Q2 25 | 5.46× | 2.49× | ||
| Q1 25 | 9.18× | 3.03× | ||
| Q4 24 | 8.88× | 1.84× | ||
| Q3 24 | 8.31× | 1.57× | ||
| Q2 24 | 3.37× | 2.87× | ||
| Q1 24 | 0.66× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KNTK
| Natural Gas NG Ls And Condensate Sales | $325.5M | 76% |
| Gathering And Processing Services | $101.6M | 24% |
| Other | $3.3M | 1% |
| Barilla Draw | $2.3M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
